ASPI Stock Overview
A development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
ASP Isotopes Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.86 |
| 52 Week High | US$5.67 |
| 52 Week Low | US$0.84 |
| Beta | 0 |
| 11 Month Change | 21.19% |
| 3 Month Change | -9.21% |
| 1 Year Change | 217.78% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 7.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| ASPI | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 5.9% | 2.6% | 2.6% |
| 1Y | 217.8% | 15.7% | 30.5% |
Return vs Industry: ASPI exceeded the US Chemicals industry which returned 15.7% over the past year.
Return vs Market: ASPI exceeded the US Market which returned 30.5% over the past year.
Price Volatility
| ASPI volatility | |
|---|---|
| ASPI Average Weekly Movement | 12.8% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ASPI's share price has been volatile over the past 3 months.
Volatility Over Time: ASPI's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 76 | Paul Mann | aspisotopes.com |
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
ASP Isotopes Inc. Fundamentals Summary
| ASPI fundamental statistics | |
|---|---|
| Market cap | US$186.72m |
| Earnings (TTM) | -US$27.05m |
| Revenue (TTM) | US$2.30m |
83.1x
P/S Ratio-7.1x
P/E RatioIs ASPI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASPI income statement (TTM) | |
|---|---|
| Revenue | US$2.30m |
| Cost of Revenue | US$1.46m |
| Gross Profit | US$838.86k |
| Other Expenses | US$27.88m |
| Earnings | -US$27.05m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 36.54% |
| Net Profit Margin | -1,178.10% |
| Debt/Equity Ratio | 202.7% |
How did ASPI perform over the long term?
See historical performance and comparison